Summary
Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company offers diagnostic systems developed with the help of Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for variety of cartridges, diseases such as pneumonia, implant and tissue infections; and in the laboratory for multiplex polymerase chain reaction (PCR) diagnostics. It caters to biotechnology, contract research, medical, healthcare and pharmaceutical companies. The company has operational presence in France, Switzerland, Netherlands, the UK, the US and Germany. It sells its products through a network of distributors in Germany and abroad. Curetis is headquartered in Holzgerlingen, Baden-Wurttemberg, Germany.
Curetis NV (CURE) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Curetis NV, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Curetis NV, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Curetis NV, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Curetis NV, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Curetis NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Curetis NV, Medical Equipment, Deal Details 12
Asset Purchase 12
Curetis to Acquire qPCR Platform from Carpegen and Systec 12
Curetis to Acquire Assets from Siemens Technology Accelerator 13
Venture Financing 14
Curetis Raises USD18 Million in Extended Series B Venture Financing 14
Curetis Raises US$16.3 Million In Series B Financing 16
Curetis Secures Additional US$13.3 Million In Series A Venture Financing 18
Partnerships 20
Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 20
Curetis Enters Into Licensing Agreement With Cempra For Unyvero 20
Acumen Research Labs Enters into Distribution Agreement with Curetis 21
Curetis Enters into Distribution Agreement with Arrow Diagnostics 22
Curetis And Laboratorios LETI Enter Into Distribution Agreement For Unyvero In Spain And Portugal 22
Curetis Enters Into Distribution Agreement With Elitech 23
Curetis Enters Into Co-Development Agreement With Heraeus Medical For Unyvero 24
Curetis Enters Into Agreement With Sanofi Pasteur For Unyvero Platform 25
Equity Offering 26
Curetis Raises USD44 Million in IPO 26
Curetis NV - Key Competitors 28
Key Employees 29
Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Financial Announcements 31
Nov 18, 2016: Curetis Publishes Business and Financial Update for the First Nine Months 2016 31
Aug 19, 2016: Curetis Reports Financial Results for the First Six Months of 2016 33
May 20, 2016: Curetis Publishes First Quarter 2016 Business and Financial Update 35
Apr 12, 2016: Curetis Publishes Full-Year 2015 Financial Results and Introduces 2016 Guidance 37
Corporate Communications 39
Jul 04, 2016: Curetis Appoints Christopher M. Bernard as Chief Executive Officer of Newly-Formed U.S. Subsidiary 39
Jan 11, 2016: Curetis Establishes Medical Advisory Board with Internationally Renowned Experts 40
Other Significant Developments 41
Jun 06, 2016: Curetis and Axonlab sign multi-market European distribution agreement 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
List of Tables
Curetis NV, Medical Equipment, Key Facts, 2015 1
Curetis NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Curetis NV, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Curetis NV, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Curetis NV, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Curetis NV, Deals By Market, 2011 to YTD 2017 9
Curetis NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Curetis to Acquire qPCR Platform from Carpegen and Systec 12
Curetis to Acquire Assets from Siemens Technology Accelerator 13
Curetis Raises USD18 Million in Extended Series B Venture Financing 14
Curetis Raises US$16.3 Million In Series B Financing 16
Curetis Secures Additional US$13.3 Million In Series A Venture Financing 18
Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 20
Curetis Enters Into Licensing Agreement With Cempra For Unyvero 20
Acumen Research Labs Enters into Distribution Agreement with Curetis 21
Curetis Enters into Distribution Agreement with Arrow Diagnostics 22
Curetis And Laboratorios LETI Enter Into Distribution Agreement For Unyvero In Spain And Portugal 22
Curetis Enters Into Distribution Agreement With Elitech 23
Curetis Enters Into Co-Development Agreement With Heraeus Medical For Unyvero 24
Curetis Enters Into Agreement With Sanofi Pasteur For Unyvero Platform 25
Curetis Raises USD44 Million in IPO 26
Curetis NV, Key Competitors 28
Curetis NV, Key Employees 29
Curetis NV, Other Locations 30
Curetis NV, Subsidiaries 30
List of Figures
Curetis NV, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Curetis NV, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Curetis NV, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Curetis NV, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Curetis NV, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Curetis NV, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
Curetis NV, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Curetis NV, Medical Equipment, Deals by Market, 2011 to YTD 2017 9
